Clearwater Capital Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Hold |
|
|||||
|
2025
Q2 | $2.23M | Hold |
|
|||||
|
2025
Q1 | $2.55M | Hold |
|
|||||
|
2024
Q4 | $2.17M | Buy |
|
|||||
|
2024
Q3 | $1.8M | Hold |
|
|||||
|
2024
Q2 | $3.05M | Buy |
|
|||||
|
2024
Q1 | $2.38M | Hold |
|
|||||
|
2023
Q4 | $2.23M | Buy |
|
|||||
|
2023
Q3 | $667K | Hold |
|
|||||
|
2023
Q2 | $1.1M | Buy |
|
|||||
|
2023
Q1 | $577K | Buy |
|
|||||
|
2022
Q4 | $943K | Hold |
|
|||||
|
2022
Q3 | $924K | Buy |
|
|||||
|
2022
Q2 | $689K | Buy |
|
|||||
|
2022
Q1 | $830K | Buy |
|
|||||
|
2021
Q4 | $855K | Sell |
|
|||||
|
2021
Q3 | $1.44M | Buy |
|
|||||
|
2021
Q2 | $1.03M | Hold |
|
|||||
|
2021
Q1 | $1.71M | Buy |
|
|||||
|
2020
Q4 | $454K | Buy |
|